Number of the records: 1  

Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function

  1. 1.
    SYSNO ASEP0571307
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleLysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
    Author(s) Uzhytchak, Mariia (FZU-D) ORCID
    Smolková, Barbora (FZU-D) ORCID
    Lunova, Mariia (FZU-D) ORCID
    Frtús, Adam (FZU-D) ORCID
    Jirsa, M. (CZ)
    Dejneka, Alexandr (FZU-D) RID, ORCID
    Lunov, Oleg (FZU-D) ORCID
    Number of authors7
    Article number114828
    Source TitleAdvanced Drug Delivery Reviews. - : ELSEVIER SCIENCE BV - ISSN 0169-409X
    Roč. 197, June (2023)
    Number of pages41 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordsnanomedicines ; nanoparticles ; drug-induced liver injury (DILI) ; endocytosis ; cytotoxicity ; lysosomes ; apoptosis ; autophagy ; cancer ; nanotoxicity
    Subject RIVBO - Biophysics
    OECD categoryBiophysics
    R&D ProjectsEF16_019/0000760 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingLimited access
    Institutional supportFZU-D - RVO:68378271
    UT WOS000989454200001
    EID SCOPUS85153295037
    DOI10.1016/j.addr.2023.114828
    AnnotationAlthough several nanomedicines got clinical approval over the past two decades, the clinical translation rate is relatively small so far. There are many post-surveillance withdrawals of nanomedicines caused by various safety issues. For successful clinical advancement of nanotechnology, it is of unmet need to realize cellular and molecular foundation of nanotoxicity. Current data suggest that lysosomal dysfunction caused by nanoparticles is emerging as the most common intracellular trigger of nanotoxicity. This review analyzes prospect mechanisms of lysosomal dysfunction-mediated toxicity induced by nanoparticles. We summarized and critically assessed adverse drug reactions of current clinically approved nanomedicines.
    WorkplaceInstitute of Physics
    ContactKristina Potocká, potocka@fzu.cz, Tel.: 220 318 579
    Year of Publishing2024
    Electronic addresshttp://doi.org/10.1016/j.addr.2023.114828
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.